Slideshows Images Quizzes

Lotemax

Last reviewed on RxList: 1/31/2017
Lotemax Side Effects Center

Medical Editor: John P. Cunha, DO, FACOEP

Last reviewed on RxList 12/22/2016

Lotemax (loteprednol etabonate) Ophthalmic Suspension is a corticosteroid used to treat eye swelling caused by surgery, infection, allergies, and other conditions. Common side effects of Lotemax Ophthalmic Suspension include:

  • stinging or burning of the eyes for 1 to 2 minutes and
  • temporary blurred vision when you apply this medication.

Other side effects of Lotemax Ophthalmic Suspension include:

  • dry eyes,
  • eye redness,
  • itchy eyes,
  • watery eyes,
  • feeling that something is in your eye,
  • being more sensitive to light,
  • headache,
  • runny nose, or
  • sore throat.

Use of Lotemax for prolonged periods or in high doses may cause serious eye problems (such as high pressure inside the eyes and cataracts). Tell your doctor if you have unlikely but serious side effects of Lotemax including:

Dose: Apply one to two drops of Lotemax into the conjunctival sac of the affected eye(s) four times daily. It is not likely that other drugs you take orally or inject will have an effect on Lotemax used in the eyes. But many drugs can interact with each other. Tell your doctor all prescription and over-the-counter medications and supplements you use. During pregnancy, Lotemax should be used only when prescribed. It is not known if the medication in this product passes into breast milk. Consult your doctor before breastfeeding.

Our Lotemax (loteprednol etabonate) Ophthalmic Suspension Side Effects Drug Center provides a comprehensive view of available drug information on the potential side effects when taking this medication.

This is not a complete list of side effects and others may occur. Call your doctor for medical advice about side effects. You may report side effects to FDA at 1-800-FDA-1088.

Lotemax Consumer Information

Get emergency medical help if you have any of these signs of an allergic reaction: hives; difficult breathing; swelling of your face, lips, tongue, or throat.

Stop using loteprednol and call your doctor at once if you have:

  • signs of a new eye infection such as swelling, redness, irritation, or drainage;
  • blurred vision, eye pain, or seeing halos around lights;
  • problems with your vision; or
  • severe pain, burning or stinging when using the eye drops.

Common side effects may include:

  • minor burning when using the eye drops;
  • dry, red, itchy, or watery eyes;
  • feeling that something is in your eye;
  • being more sensitive to light;
  • headache; or
  • runny nose, sore throat.

This is not a complete list of side effects and others may occur. Call your doctor for medical advice about side effects. You may report side effects to FDA at 1-800-FDA-1088.

Read the entire detailed patient monograph for Lotemax (Loteprednol Etabonate Ophthalmic Suspension)

Lotemax Professional Information

SIDE EFFECTS

Reactions associated with ophthalmic steroids include elevated intraocular pressure, which may be associated with optic nerve damage, visual acuity and field defects, posterior subcapsular cataract formation, secondary ocular infection from pathogens including herpes simplex, and perforation of the globe where there is thinning of the cornea or sclera.

Ocular adverse reactions occurring in 5-15% of patients treated with loteprednol etabonate ophthalmic suspension (0.2%-0.5%) in clinical studies included abnormal vision/blurring, burning on instillation, chemosis, discharge, dry eyes, epiphora, foreign body sensation, itching, injection, and photophobia. Other ocular adverse reactions occurring in less than 5% of patients include conjunctivitis, corneal abnormalities, eyelid erythema, keratoconjunctivitis, ocular irritation/pain/discomfort, papillae, and uveitis. Some of these events were similar to the underlying ocular disease being studied.

Non-ocular adverse reactions occurred in less than 15% of patients. These include headache, rhinitis and pharyngitis.

In a summation of controlled, randomized studies of individuals treated for 28 days or longer with loteprednol etabonate, the incidence of significant elevation of intraocular pressure ( ≥ 10 mmHg) was 2% (15/901) among patients receiving loteprednol etabonate, 7% (11/164) among patients receiving 1% prednisolone acetate and 0.5% (3/583) among patients receiving placebo.

Read the entire FDA prescribing information for Lotemax (Loteprednol Etabonate Ophthalmic Suspension)

Related Resources for Lotemax

Read the Lotemax User Reviews »

© Lotemax Patient Information is supplied by Cerner Multum, Inc. and Lotemax Consumer information is supplied by First Databank, Inc., used under license and subject to their respective copyrights.

Health Solutions From Our Sponsors